Standardised, Streamlined, Single-Cell: The Protocols of PERSIST-SEQ

20 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Welcome to episode 4 of the PERSIST-SEQ video series, where we take you behind the scenes of cutting edge-research into treatment-resistant cancers. In this episode, we speak with Mauro Muraro, Dylan Mooijman, and Oriol Llorà-Batlle from Single Cell Discoveries, a key partner in this EU-funded consortium.

In this video, you’ll hear about:

???? How Single Cell Discoveries enables standardised single-cell sequencing across PERSIST-SEQ

???? Why centralisation and standardisation matter in cancer research, especially for building a large-scale atlas of persister cell biology that will be openly shared with the global scientific community

???? How cutting-edge technologies like single-cell and spatial transcriptomics are transforming our understanding of cancer

What is PERSIST-SEQ?

PERSIST-SEQ is an Innovative Medicines Initiative 2 project. This public-private partnership investigates why and how tumours persist. By using single-cell sequencing, patient-derived organoids and xenografts, researchers across Europe aim to create reproducible workflows for studying tumour persistence. The consortium focuses on understanding tumour plasticity, particularly drug-tolerant persister cells.

To learn more about PERSIST-SEQ:

Head to our website https://persist-seq.org/

Find us on LinkedIn https://www.linkedin.com/shareArticle?url=https://persist-seq.org/contact&source=

If you have any questions about PERSIST-SEQ, please contact the PERSIST-SEQ secretariat: [email protected]

????‍????Who is this video for?

????Cancer researchers and clinicians

???? Policy makers, regulators and healthcare innovators

???? Patients, advocates, and curious members of the public

Keywords:

Cancer research, oncology, therapeutic resistance, drug resistance, single cell sequencing, spatial transcriptomics, open science, patient derived organoids, patient derived xenografts, collaboration, personalised medicine, science communication #cancer #research #oncology
Categoria
Oncology
Commenta per primo questo video.

Prossimo